Medical Program: Why Patients Settle for Insufficient RA Therapies & How to Intervene

Why Patients Settle for Insufficient RA Therapies & How to Intervene

Why Patients Settle for Insufficient RA Therapies & How to Intervene
RestartResume
Dr. Jeffrey Curtis explores the reasons why RA patients resign themselves to settling for treatments that aren't fully successful.
  • Overview

    Dr. Jeffrey Curtis, William J. Koopman Endowed Professor in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, talks about the problem of settling for insufficient therapeutic responses in RA treatments, how to recognize when it's happening, and what health professionals can do to curb the trend.

    Rheumatoid Arthritis: Addressing Unmet Needs is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

Facebook Comments

Sign up for the Rheumatology Academy newsletters.
Comprehensive Rheumatology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Rheumatology Academy…
but how about a more personalized experience?

Register for free